Is the Whole Greater Than the Sum of Its Parts?

REFERENCES

1. 1.↵
   1. Gandhi R,
   2. Razak F,
   3. Davey JR,
   4. Mahomed NN

   . Metabolic syndrome and the functional outcomes of hip and knee arthroplasty. J Rheumatol 2010;37:1917–22.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Montin L,
   2. Leino-Kilpi H,
   3. Suominen T,
   4. Lepisto J

   . A systematic review of empirical studies between 1966 and 2005 of patient outcomes of total hip arthroplasty and related factors. J Clin Nursing 2008;17:40–5.

   OpenUrlPubMed
3. 3.↵
   1. Santaguida PL,
   2. Hawker GA,
   3. Hudak PL,
   4. Glazier R,
   5. Mahomed NN,
   6. Kreder HJ,
   7. et al.

   Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review. Can J Surg 2008;51:428–36.

   OpenUrlPubMed
4. 4.↵
   1. Jackson MP,
   2. Sexton SA,
   3. Yeung E,
   4. Walter WL,
   5. Walter WK,
   6. Zicat BA

   . The effect of obesity on the mid-term survival and clinical outcome of cementless total hip replacement. J Bone Joint Surg Br 2009;91:1296–300.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Dowsey MM,
   2. Choong P

   . Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Rel Res 2008;466:153–8.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Malinzak RA,
   2. Ritter MA,
   3. Berend ME,
   4. Meding JB,
   5. Olberding EM,
   6. Davis KE

   . Morbidly obese, diabetic, younger and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates. J Arthroplasty 2009;24 Suppl:84–8.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Kahn R,
   2. Buse J,
   3. Ferrannini E,
   4. Stern M

   . The metabolic syndrome: time for a critical appraisal. Diab Care 2005;28:2289–304.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Meigs JB,
   2. Wilson PWF,
   3. Fox CS,
   4. Vasan RS,
   5. Nathan DM,
   6. Sullivan L,
   7. et al.

   Body mass index, metabolic syndrome and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906–12.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Grundy SM,
   2. Brewer HB Jr.,
   3. Cleeman JI,
   4. Smith SC Jr.,
   5. Lenfant C,
   6. American Heart Association; National Heart, Lung, and Blood Institute

   . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433–8.

   OpenUrlFREE Full Text
10. 10.↵
    1. Stürmer T,
    2. Brenner H,
    3. Koenig W,
    4. Günther KP

    . Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high-sensitivity C-reactive protein. Ann Rheum Dis 2004;63:200–5.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Stürmer T,
    2. Raum E,
    3. Buchner M,
    4. Gebhardt K,
    5. Schiltenwolf M,
    6. Richter W,
    7. et al.

    Pain and high-sensitivity C-reactive protein in patients with chronic low back pain and acute sciatic pain. Ann Rheum Dis 2005;64:921–5.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Stürmer T,
    2. Buring JE,
    3. Lee IM,
    4. Gaziano JM,
    5. Glynn RJ

    . Metabolic abnormalities and risk for colorectal cancer in the Physicians’ Health Study. Cancer Epidemiol Biomarkers Prev 2006;15:2391–7.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Stürmer T,
    2. Dreinhöfer K,
    3. Gröber-Grätz D,
    4. Brenner H,
    5. Dieppe P,
    6. Puhl W,
    7. et al.

    Differences in the views of orthopaedic surgeons and referring practitioners on the determinants of outcome after total hip replacement. J Bone Joint Surg Br 2005;87:1416–9.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Solomon DH,
    2. Avorn J,
    3. Wang PS,
    4. Vaillant G,
    5. Cabral D,
    6. Mogun H,
    7. et al.

    Prescription opioid use among older adults with arthritis or low back pain. Arthritis Rheum 2006;55:35–41.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Huch K,
    2. Müller KAC,
    3. Stürmer T,
    4. Brenner H,
    5. Puhl W,
    6. Günther KP

    . Sports activities 5 years after total knee or hip arthroplasty: the Ulm Osteoarthritis Study. Ann Rheum Dis 2005;64:1715–20.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Sun Y,
    2. Stürmer T,
    3. Günther KP,
    4. Brenner H

    . Reliability and validity of clinical outcome measurements of osteoarthritis of the hip and knee — a review of the literature. Clin Rheumatol 1997;16:185–98.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Stürmer T,
    2. Sun Y,
    3. Sauerland S,
    4. Zeissig I,
    5. Günther KP,
    6. Puhl W,
    7. et al.

    Serum cholesterol and osteoarthritis. The baseline examination of the Ulm Osteoarthritis Study. J Rheumatol 1998;25:1827–32.

    OpenUrlPubMed
18. 18.↵
    1. Stürmer T,
    2. Günther KP,
    3. Brenner H

    . Obesity, overweight and patterns of osteoarthritis: the Ulm Osteoarthritis Study. J Clin Epidemiol 2000;53:307–13.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Stürmer T,
    2. Brenner H,
    3. Brenner R,
    4. Günther KP

    . Noninsulin dependent diabetes mellitus and patterns of osteoarthritis — the Ulm Osteoarthritis Study. Scand J Rheumatol 2001;30:169–71.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Committee on Comparative Effectiveness Research Prioritization, Institute of Medicine

    . Initial national priorities for comparative effectiveness research. Washington: National Academies Press; 2009:252.